In today’s session Monsanto Company (MON) registered an unusually high (455) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious MON increase. With 455 contracts traded and 1004 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: MON161216C00100000 closed last at: $4.25 or 1.2% up. About 1.42 million shares traded hands. Monsanto Company (NYSE:MON) has risen 19.75% since March 2, 2016 and is uptrending. It has outperformed by 11.50% the S&P500.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. $134 is the highest target while $83 is the lowest. The $111.50 average target is 8.77% above today’s ($102.51) stock price. Monsanto Company has been the topic of 38 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The firm has “Neutral” rating by Citigroup given on Friday, July 1. On Friday, October 9 the stock rating was maintained by Argus Research with “Buy”. Deutsche Bank maintained Monsanto Company (NYSE:MON) on Thursday, October 8 with “Buy” rating. On Monday, April 11 the stock rating was maintained by Goldman Sachs with “Sell”. As per Friday, September 11, the company rating was initiated by Bernstein. The firm earned “Overweight” rating on Wednesday, September 21 by JP Morgan. The stock of Monsanto Company (NYSE:MON) has “Buy” rating given on Friday, October 9 by Stifel Nicolaus. As per Tuesday, June 14, the company rating was maintained by UBS. On Friday, August 19 the stock rating was maintained by Citigroup with “Neutral”. The firm has “Mkt Perform” rating given on Monday, September 26 by Bernstein.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 0.91 in 2016 Q2. Its up 0.10, from 0.81 in 2016Q1. The ratio improved, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Armstrong Henry H Assoc holds 0.06% or 2,860 shares in its portfolio. M&T Comml Bank reported 240,813 shares or 0.17% of all its holdings. Hap Trading Ltd Liability Company last reported 555,213 shares in the company. Advisory Serv Ntwk Ltd Llc has invested 0.02% of its portfolio in Monsanto Company (NYSE:MON). Pittenger & Anderson has invested 0.03% of its portfolio in Monsanto Company (NYSE:MON). Factory Mutual Ins holds 0.52% or 379,900 shares in its portfolio. Schulhoff Inc accumulated 3,000 shares or 0.19% of the stock. Adams Natural Resource Fund holds 2.15% or 132,500 shares in its portfolio. Autus Asset Lc has invested 0.19% of its portfolio in Monsanto Company (NYSE:MON). Oakworth Cap holds 0.01% of its portfolio in Monsanto Company (NYSE:MON) for 209 shares. Westpac Bk Corp holds 0% of its portfolio in Monsanto Company (NYSE:MON) for 170,995 shares. Daiwa Securities last reported 0.02% of its portfolio in the stock. Highfields Cap Lp holds 0.45% of its portfolio in Monsanto Company (NYSE:MON) for 500,000 shares. Hanseatic Mgmt Svcs last reported 0.22% of its portfolio in the stock. Cibc Ww Markets accumulated 0% or 6,620 shares.
Insider Transactions: Since April 11, 2016, the stock had 1 buy, and 4 sales for $1.16 million net activity. Shares for $338,793 were sold by MIZELL STEVEN. The insider Frank Michael J sold 2,000 shares worth $174,984. MCMILLAN CHARLES S bought $305,375 worth of stock. POSTE GEORGE sold $104,428 worth of Monsanto Company (NYSE:MON) on Tuesday, April 19.
Monsanto Company , along with its subsidiaries, is a well-known provider of agricultural products for farmers. The company has a market cap of $44.72 billion. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. It has a 43.13 P/E ratio. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
More notable recent Monsanto Company (NYSE:MON) news were published by: Businesswire.com which released: “Monsanto and Dow AgroSciences Announce Global Licensing Agreement on EXZACT …” on October 03, 2016, also Foxbusiness.com with their article: “Monsanto’s 4Q Loss Narrows as Expenses Drop” published on October 05, 2016, Businesswire.com published: “Monsanto Company Sets Webcast and Analyst/Media Call for Fourth Quarter and …” on September 28, 2016. More interesting news about Monsanto Company (NYSE:MON) were released by: Qz.com and their article: “Six companies are about to merge into the biggest farm-business oligopoly in …” published on September 20, 2016 as well as Fool.com‘s news article titled: “What Will Investors Harvest From Bayer’s Buyout of Monsanto?” with publication date: October 04, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.